top of page

CEO Clips: Resverlogix (TSX: RVX) | The Future of Drug Development



Resverlogix Corp. (TSX: RVX) is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions to key partners.


The Company was founded in 2001 by Donald McCaffrey and Norman Wong. They’re a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.


They provide novel science, clinical, and value-based health solutions to key stakeholders such as pharmaceutical, physician, and health payer groups.


Subscribe to receive more investment opportunities videos: http://bit.ly/Subscribe2BTV

Check out more videos: BTV Business Television episodes: http://bit.ly/2UBerea






Recent Posts

See All

Comentarios


© 2023 Frontier Merchant Capital Group. All Rights Reserved.

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
bottom of page